Povidone Iodine Versus Normal Saline in Preoperative Vaginal Cleansing Before Caesarean Section
Efficacy and Safety of Povidone Iodine Versus Normal Saline in Preoperative Vaginal Cleansing Before Caesarean Section: A Randomized Controlled Trial
1 other identifier
interventional
224
1 country
1
Brief Summary
Post-caesarean maternal infectious morbidity is still a big challenge despite prophylactic antibiotics and preoperative vaginal cleansing with povidone-iodine use in reduction of post-caesarean endometritis.Povidone iodine has been found to cause significant irritation to the vaginal mucosa especially in females with iodine hypersensitivity necessitating the study of efficacy of normal saline which has minimal side effects in the prevention of post caesarean complications
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2021
CompletedFirst Submitted
Initial submission to the registry
April 22, 2025
CompletedFirst Posted
Study publicly available on registry
April 30, 2025
CompletedMay 2, 2025
April 1, 2025
5 months
April 22, 2025
April 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Post caesarean endometritis.
Patient that has at least two or more of the following signs and symptoms with no other recognized cause: fever greater than or equal to 380c, abdominal pain, uterine tenderness and purulent drainage from the uterus
24 hours
Post operative vaginal irritation
presence of symptoms like itching, burning, swelling and vaginal pain following the vaginal cleansing with either 5% povidone iodine or normal saline solution.
24 hours
Study Arms (2)
Povidone group
ACTIVE COMPARATORHundred (100) ml of 5% povidone iodine was poured into a sterilized bowl (galipot). Three pieces of gauze held with sponge holding forceps was dipped into the sterilized bowl containing 100mls of 5% povidone iodine and was allowed to be well soaked with 5% povidone iodine and thereafter used to swab the vulva in 360 degrees. one gram of ceftriaxone and 500mg of metronidazole was given prior to the procedure.
Normal Saline
EXPERIMENTALHundred (100) ml of Normal saline was poured into a sterilized bowl (galipot). Three pieces of gauze held with sponge holding forceps was dipped into the sterilized bowl containing 100mls of Normal saline and was allowed to be well soaked with Normal saline and thereafter used to swab the vulva in 360 degrees. one gram of ceftriaxone and 500mg of metronidazole was given prior to the procedure.
Interventions
Hundred (100) ml of 5% povidone iodine was poured into a sterilized bowl (galipot). Three pieces of gauze held with sponge holding forceps was dipped into the sterilized bowl containing 100mls of 5% povidone iodine and was allowed to be well soaked with 5% povidone iodine and thereafter used to swab the vulva in 360 degrees. one gram of ceftriaxone and 500mg of metronidazole was given prior to the procedure.
Hundred (100) ml of Normal saline was poured into a sterilized bowl (galipot). Three pieces of gauze held with sponge holding forceps was dipped into the sterilized bowl containing 100mls of Normal Saline and was allowed to be well soaked with Normal saline and thereafter used to swab the vulva in 360 degrees. one gram of ceftriaxone and 500 mg of metronidazole was given prior to the procedure.
Eligibility Criteria
You may qualify if:
- All consenting parturient for either elective or emergency caesarean section after the age of viability
You may not qualify if:
- Women with known allergy to topical povidone-iodine.
- Women with presence of pre-existing vaginal irritation symptoms as itching, burning, swelling and vaginal pain.
- Antepartum haemorrhage (Placenta praevia).
- Cord prolapse
- Clinical evidence of Chorioamnionitis
- Face presentation with ruptured membranes to avoid contact of fetal face with iodine.
- Women with immunosupression due to HIV/AIDS, Diabetes Miletus or chronic use of steroids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, 480101, Nigeria
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 22, 2025
First Posted
April 30, 2025
Study Start
October 6, 2020
Primary Completion
March 9, 2021
Study Completion
March 9, 2021
Last Updated
May 2, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share